Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Desmond H. Y. Tse

28 indexed publications match this author name.

ORCID: 0000-0003-2559-7707
OpenAlex: https://openalex.org/A5062957500

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 11 Mechanism of Action 9 Clinical Trial 8 Safety 8 Receptor Pharmacology 8 Animal Study 6 Addiction 5 Brain Imaging 5 Aging 5 Neuroplasticity 5 Anxiety 4 Healthy Volunteers 4

Journals

Biological Psychiatry 3 Frontiers in psychiatry 2 ClinicalTrials.gov 1 Nature neuroscience 1 Journal of psychopharmacology (Oxford, England) 1 Progress in neuro-psychopharmacology & biological psychiatry 1 Alzheimer's & dementia: the journal of the Alzheimer's Association 1 Cureus 1

Publication history

A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06 Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal CortexhBiological Psychiatry · 2026-05-01 The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures.Journal of psychopharmacology (Oxford, England) · 2026-05-01 Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20 Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging studyAlzheimer's & dementia: the journal of the Alzheimer's Association · 2025-12-01 Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine Exposure.Cureus · 2025-11-01 13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-09 The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex.Molecular brain · 2025-03-18 Vermont Primary Care Provider Perspectives on Psychedelics - A Cross-Sectional Study.Journal of psychoactive drugs · 2025-03-05 Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortexbioRxiv · 2025-01-08 Theoretical Description for Psilocin and Coprine Electrochemical Determination in Mushroom Pulp and Biological Liquids over Cobalt (II) Oxyhydroxide-Modified ElectrodeLetters in Applied NanoBioScience · 2024-12-30 Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.BMJ (Clinical research ed.) · 2024-08-21 Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor.iScience · 2024-05-17 The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.Frontiers in psychiatry · 2024-01-01 Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybinMedical Writing · 2023-12-11 Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study.Brain, behavior, and immunity · 2023-11-01 Pharmacognostic, Forensic and Pharmaceutical, Organizational and Legal, Clinical and Pharmacological Multidisciplinary Study with an Assessment of Peculiarities of Circulation (Use) of Smoking Mixtures of Spices and Entheogens of Amanita Muscaria MushroomSSP Modern Pharmacy and Medicine · 2023-07-18 118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-10 Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-05 Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteersmedRxiv · 2022-11-01 Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.Journal of clinical medicine · 2022-02-11 Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.Psychiatry investigation · 2021-10-01 Spontaneous and deliberate creative cognition during and after psilocybin exposure.Translational psychiatry · 2021-04-08 Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2020-11-01 P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective stateEuropean Neuropsychopharmacology · 2020-01-28 Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography.Frontiers in psychiatry · 2020-01-01 Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The international journal of neuropsychopharmacology · 2016-07-01

Author directory